[Usage]
Leedin SARS-CoV-2 nucleic acid detection kit adopts real-time fluorescent reverse transcription PCR (RT-PCR) detection method to quickly and qualitatively detect novel coronavirus in samples collected from the oropharyngeal swabs, nasopharyngeal swabs and sputum collector.
The test can be used as an auxiliary method to diagnose coronavirus infection (COVID-19) and provide preliminary test results. A negative result does not mean that there is no 2019-nCoV infection, and cannot be used as the only basis for diagnosis, treatment and management decisions.
For in vitro diagnostic use only. For professional use only.
[Summary]
The SARS-CoV-2 virus belongs to the coronavirus family and causes an acute respiratory infection. Since the outbreak of the COVID-19 outbreak at the end of 2019, tens of millions of SARS-CoV-2 infections have been confirmed. It is evolving into one of the greatest challenges to global public health in history.
At present, patients infected with the novel coronavirus are the main source of infection, and asymptomatic carriers of the virus may also be the source of infection. According to the current epidemiological survey, the incubation period is 1 to 14 days, mostly 3 to 7 days.The main manilestatons include fever fatque anddrycoughNasal congestion runny nose, sore throat, myalga and diamhea are loundinafew cases. Early detection of COVID-19 is very important for timely medical intervention and control of the spread.
The novel coronavirus nucleic acid detection kit developed by Leedin Biotech Co., Ltd is designed to quickly and accurately detect the novel coronavirus and assist in the diagnosis and treatment of patients with novel coronary pneumonia and public health management.